proline has been researched along with melphalan in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bielawska, A; Bielawski, K; Chrzanowski, K; Pałka, J; Wołczyński, S | 1 |
Chrzanowski, K; Pałka, J | 1 |
Bielawska, A; Chrzanowski, K; Pałka, J | 1 |
Alessi, P; Heinis, C; Neri, D | 1 |
Amidon, GL; Mittal, S; Song, X; Vig, BS | 1 |
Amidon, GL; Hilfinger, JM; Landowski, CP; Lee, KD; Mittal, S; Tsume, Y | 1 |
Cho, DH; Hur, DY; Kim, D; Kim, S; Kim, YS; Lee, HK; Lee, WJ; Park, GB | 1 |
Amidon, GL; Dahan, A; Landowski, CP; Mittal, S; Wolk, O; Wu, Z; Yang, P | 1 |
8 other study(ies) available for proline and melphalan
Article | Year |
---|---|
Cytotoxicity and effect on collagen biosynthesis of proline analogue of melphalan as a prolidase-convertible prodrug in cultured human skin fibroblasts.
Topics: Antineoplastic Agents, Alkylating; Cell Survival; Cells, Cultured; Child; Collagen; Dipeptidases; Fibroblasts; Humans; Male; Melphalan; Prodrugs; Proline; Skin | 2001 |
Proline analogue of melphalan as a prolidase-convertible pro-drug in breast cancer MCF-7 cells.
Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Dipeptidases; Female; Humans; Melphalan; Prodrugs; Proline; Tumor Cells, Cultured | 2001 |
Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dipeptidases; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Melphalan; Prodrugs; Proline | 2003 |
Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy.
Topics: Animals; Antibodies; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Directed Molecular Evolution; Drug Design; Enzyme Stability; Humans; Immunoconjugates; Melphalan; Mice; Molecular Structure; Peptides; Prodrugs; Proline; Prolyl Oligopeptidases; Protein Engineering; Serine Endopeptidases; Toxicity Tests | 2004 |
Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
Topics: Antineoplastic Agents, Alkylating; Biological Transport; Biotransformation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chlorambucil; Dipeptidases; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrolysis; Inhibitory Concentration 50; Melanoma; Melphalan; Prodrugs; Proline; Protease Inhibitors; RNA, Messenger; Stereoisomerism | 2007 |
Proline prodrug of melphalan, prophalan-L, demonstrates high therapeutic index in a murine melanoma model.
Topics: Animals; Antineoplastic Agents, Alkylating; Body Weight; Calorimetry; Cell Proliferation; Chromatography, High Pressure Liquid; Female; Hydrolysis; Indicators and Reagents; Melanoma, Experimental; Melphalan; Mice; Mice, Inbred C57BL; Prodrugs; Proline; Spectrophotometry, Ultraviolet; Stereoisomerism; Survival Analysis | 2007 |
Melphalan-induced apoptosis of EBV-transformed B cells through upregulation of TAp73 and XAF1 and nuclear import of XPA.
Topics: Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Alkylating; Apoptosis; Apoptosis Regulatory Proteins; B-Lymphocytes; bcl-2-Associated X Protein; Caspases; Cell Transformation, Viral; Cells, Cultured; DNA-Binding Proteins; Enzyme Activation; Gene Expression Regulation; Herpesvirus 4, Human; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Melphalan; Mitochondria; Neoplasm Proteins; Nuclear Proteins; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proline; Protein Interaction Mapping; Protein Isoforms; Protein Processing, Post-Translational; Protein Structure, Tertiary; Proto-Oncogene Proteins; Pyridines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Transcriptional Activation; Tumor Protein p73; Tumor Suppressor Proteins; Xeroderma Pigmentosum Group A Protein | 2013 |
Dipeptidyl peptidase IV as a potential target for selective prodrug activation and chemotherapeutic action in cancers.
Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Dipeptides; Dipeptidyl Peptidase 4; Humans; Melphalan; Neoplasms; Oligopeptides; Prodrugs; Proline; Swine | 2014 |